FDA: Class III devices will require a PMA

Manufacturers of all Class III devices soon could be required to either go through the pre-market approval (PMA) process or reclassify their devices, according to the FDA.

FDA News
reported that the agency’s decision is in response to a Government Accountability Office (GAO) report released last week, which recommends that the FDA “expeditiously take steps” to require all Class III devices to obtain a PMA or be reclassified.

The GAO report sad that the FDA had cleared more than 200 high-risk Class III devices, and go through a less stringent review process that was intended for simpler products.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.